ReviewHypertension (Dallas, Tex. : 1979)2017
Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.
Review in Hypertension (Dallas, Tex. : 1979), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Comparative effect of antihypertensive drugs in improving arterial stiffness in adults with hypertension (RIGIPREV study). A network meta-analysis.Frontiers in pharmacology · 2023Pooled it
- New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies.Frontiers in endocrinology · 2021Pooled it
- Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.Hypertension (Dallas, Tex. : 1979) · 2020Trial
- Aldosterone synthase inhibitors for the treatment of cardiovascular disease.Nature reviews. Endocrinology · 2026Review
- Aldosterone Effect on Cardiac Structure and Function.Current cardiology reviews · 2024Review
- Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.Journal of human hypertension · 2023Article
- A New Lignan fromMolecules (Basel, Switzerland) · 2023Article
- Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes.Frontiers in endocrinology · 2023Article
- Genetic inhibition of serum glucocorticoid kinase 1 prevents obesity-related atrial fibrillation.JCI insight · 2022Article
- Stroke Risks in Primary Aldosteronism with Different Treatments: A Systematic Review and Meta-Analysis.Journal of cardiovascular development and disease · 2022Review
- Bidirectional Association Between Kidney Function and Atrial Fibrillation: A Population-Based Cohort Study.Journal of the American Heart Association · 2022Article
- Transcriptomic profile analysis of the left atrium in spontaneously hypertensive rats in the early stage.Frontiers in pharmacology · 2022Article
- Treatment of Primary Aldosteronism and Reversal of Renin Suppression Improves Left Ventricular Systolic Function.Frontiers in endocrinology · 2022Observational
- The Herbicide Atrazine Potentiates Angiotensin II-Induced Aldosterone Synthesis and Release From Adrenal Cells.Frontiers in endocrinology · 2021Article
- Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.The Journal of clinical endocrinology and metabolism · 2020Review
- Consensus paper on the evaluation and treatment of resistant hypertension by the Turkish Society of Cardiology.Anatolian journal of cardiology · 2020Article
- Influence of Different Treatment Strategies on New-Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort-Based Study.Journal of the American Heart Association · 2020Article
- Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management.Journal of human hypertension · 2019Review
- Arterial Hypertension, Aldosterone, and Atrial Fibrillation.Current hypertension reports · 2019Review
- The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.Endocrine reviews · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.